Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency

Journal of Internal Medicine

Volumn 253, Issue 2, 2003, Pages 208-216

  Kaser, S ^a   Sandhofer, A ^a   Holzl B ^b   Gander, R ^a   Ebenbichler, C F ^a   Paulweber, B ^b   Patsch, Josef R ^a,c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b St Johanns Spital   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Cholesteryl ester transfer; HDL; Lipoprotein lipase deficiency; Phospholipid transfer

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; MALE; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL;

ADULT; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; FEMALE; GLYCOPROTEINS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; PHOSPHOLIPIDS;

EID: 0037318630     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01091.x     Document Type: Article

References (44)

1. Havel RJ, Kane JP, Kashyap ML. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest 1973; 52: 32-8.
2. Mjos OD, Faergeman O, Hamilton RL, Havel RJ. Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat. J Clin Invest 1975; 56: 603-15.
3. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, van Tol A, Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993; 268: 4032-6.
4. Tu AY, Nishida HI, Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 1993; 268: 23098-105.
5. Settasatian N, Duong M, Curtiss LK et al. The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. J Biol Chem 2001; 276: 26898-905.
6. Von Eckardstein A, Jauhiainen M, Huang Y et al. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim Biophys Acta 1996; 1301: 255-62.
7. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry 1988; 27: 25-9.
8. Jiang XC, Bruce C, Mar J et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 1999; 103: 907-14.
9. Van Haperen R, van Tol A, Vermeulen P et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 2000; 20: 1082-8.
10. Foger B, Santamarina-Fojo S, Shamburek RD, Parrot CL, Talley GD, Brewer HB, Jr. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J Biol Chem 1997; 272: 27393-400.
11. Ehnholm S, van Dijk KW, van't Hof B et al. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J Lipid Res 1998; 39: 1248-53.
12. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34: 1255-74.
13. Morton RE, Zilversmit DB. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J Lipid Res 1982; 23: 1058-67.
14. Patsch JR. Triglyceride-rich lipoproteins and atherosclerosis. Atherosclerosis 1994; 110 (Suppl.): S23-6.
15. Sammett D, Tall AR. Mechanisms of enhancement of cholesteryl ester transfer protein activity by lipolysis. J Biol Chem 1985; 260: 6687-97.
16. Bagdade JD, Ritter MC, Lithell H et al. Reduced cholesteryl ester transfer in plasma of patients with lipoprotein lipase deficiency. J Lipid Res 1996; 37: 1696-703.
17. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996; 37: 693-707.
18. Mead JR, Cryer A, Ramji DP. Lipoprotein lipase, a key role in atherosclerosis? FEBS Lett 1999; 462: 1-6.
19. Gilbert B, Rouis M, Griglio S, de Lumley L, Laplaud P. Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations; 75% are clustered in exons 5 and 6. Ann Genet 2001; 44: 25-32.
20. Nordestgaard BG, Abildgaard S, Wittrup HH, Steffensen R, Jensen G, Tybjaerg-Hansen A. Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation 1997; 96: 1737-44.
21. Fellin R, Baggio G, Poli A et al. Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives. Atherosclerosis 1983; 49: 55-68.
22. Wilson DE, Edwards CQ, Chan IF. Phenotypic heterogeneity in the extended pedigree of a proband with lipoprotein lipase deficiency. Metabolism 1983; 32: 1107-14.
23. Wilson DE, Emi M, Iverius PH et al. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest 1990; 86: 735-50.
24. Miesenbock G, Holzl B, Foger Bet al. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest 1993; 91: 448-55.
25. Mailly F, Tugrul Y, Reymer PW et al. A common variant in the gene for lipoprotein lipase (Asp9 → Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 1995; 15: 468-78.
26. Bijvoet S, Gagne SE, Moorjani S et al. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. J Lipid Res 1996; 37: 640-50.
27. Holzl B, Huber R, Paulweber B, Patsch JR, Sandhofer F. Lipoprotein lipase deficiency due to a 3′ splice site mutation in intron 6 of the lipoprotein lipase gene. J Lipid Res 1994; 35: 2161-9.
28. Paulweber B, Wiebusch H, Miesenboeck G et al. Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia. Atherosclerosis 1991; 86: 239-50.
29. Kaser S, Sandhofer A, Foger B et al. Influence of obesity and insulin sensitivity on phospholipid transfer protein activity. Diabetologia 2001; 44: 1111-7.
30. Patsch JR, Patsch W. Zonal ultracentrifugation. Methods Enzymol 1986; 129: 3-26.
31. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982; 28: 1379-88.
32. Patsch W, Brown SA, Morrisett JD, Gotto AM, Jr, Patsch JR. A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma. Clin Chem 1989; 35: 265-70.
33. Kaser S, Ebenbichler CF, Wolf HJ et al. Lipoprotein profile and cholesteryl ester transfer protein in neonates. Metabolism 2001; 50: 723-8.
34. Groener JE, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 1986; 32: 283-6.
35. Shimada M, Ishibashi S, Inaba T et al. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc Natl Acad Sci USA 1996; 93: 7242-6.
36. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975; 1: 16-9.
37. Desrumaux C, Athias A, Bessede G et al. Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. Arterioscler Thromb Vasc Biol 1999; 19: 266-75.
38. Mann CJ, Yen FT, Grant AM, Biahin BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991; 88: 2059-66.
39. Murakami T, Michelagnoli S, Longhi R et al. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol 1995; 15: 1819-28.
40. Jiang XC, Bruce C, Mar J et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density-lipoprotein levels. J Clin Invest 1999; 103: 907-14.
41. Colhoun HM, Scheek LM, Rubens MB et al. Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes 2001; 50: 652-9.
42. Hayek T, Masucci-Magoulas L, Jiang X et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995; 96: 2071-4.
43. Inazu A, Brown ML, Hesler CB et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990; 323: 1234-8.
44. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 2000; 101: 1907-12.